Scott Joseph Antonia, MD, PhD

Professor of Medicine
Member of the Duke Cancer Institute
Email address scott.antonia@duke.edu

Education and Training

  • Postdoctoral Fellowship, Immunobiology, Yale University School of Medicine, 1992 - 1994
  • Medical Oncology Fellowship, Yale University School of Medicine, 1991 - 1994
  • Internal Medicine Residency, Yale University School of Medicine, 1989 - 1991
  • M.D., University of Connecticut, School of Medicine, 1989
  • Ph.D., University of Connecticut, School of Medicine, 1987

Publications

Scherpereel, Arnaud, Scott Antonia, Yolanda Bautista, Francesco Grossi, Dariusz Kowalski, Gérard Zalcman, Anna K. Nowak, et al. “First-line nivolumab plus ipilimumab versus chemotherapy for the treatment of unresectable malignant pleural mesothelioma: patient-reported outcomes in CheckMate 743.” Lung Cancer 167 (May 2022): 8–16. https://doi.org/10.1016/j.lungcan.2022.03.012.

PMID
35367910
Full Text

Antonia, Scott J., Hossein Borghaei, Suresh S. Ramalingam, Leora Horn, Javier De Castro Carpeño, Adam Pluzanski, Marco A. Burgio, et al. “Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis.” Lancet Oncol 20, no. 10 (October 2019): 1395–1408. https://doi.org/10.1016/S1470-2045(19)30407-3.

PMID
31422028
Full Text